Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantHemic and Lymphatic Diseases, Neoplasms by Site, graft versus host disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, neoplasmRecruitingPhase 22026-06-29NCT07006506

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Memorial Sloan Kettering Cancer Center753

8 results · Page 1 of 1